Vogenx director reports 1.8M-share stake
Vogenx, Inc. (VOGX) reported initial insider ownership for director and Chief Scientific Officer Dr. William Wilkison and affiliated entity WOWIG, LLC.
Rhea-AI Filing Summary
Vogenx, Inc. (VOGX) reported initial insider ownership for director and Chief Scientific Officer Dr. William Wilkison and affiliated entity WOWIG, LLC. Dr. Wilkison holds stock options to acquire up to 116,666 shares of common stock at an exercise price of $1.03 per share, fully vested and exercisable, expiring on July 27, 2027. He also holds options covering 26,666 shares at an exercise price of $1.26 per share, vesting in three annual tranches from April 1, 2026 through April 1, 2028, expiring on January 1, 2031. In addition, 1,800,000 shares of common stock are held indirectly through WOWIG, LLC, of which Dr. Wilkison is the sole member and which is the direct owner of those securities.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Wilkison William, WOWIG, LLC
Role
Chief Scientific Officer | 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) F2, F3 | -- | -- | -- |
| holding | Stock Option (right to buy) F4, F3 | -- | -- | -- |
| holding | Common Stock F1 | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 143,332 contracts (Direct);
Common Stock — 1,800,000 shares (Indirect, See Note 1)
Footnotes (4)
- F1. William Wilkison is the sole member of WOWIG, LLC, the direct owner of the securities.
- F2. The shares subject to this option are fully vested and exercisable as of the date hereof.
- F3. The securities are owned directly by Dr. Wilkison.
- F4. The shares subject to this option vest as to 8,889 shares on April 1, 2026, 8,889 shares on April 1, 2027, and 8,888 shares on April 1, 2028, subject to Dr. Wilkison's continued service on each such vesting date.
Key Figures
Option exercise price: $1.03 per share
Underlying shares for $1.03 option: 116,666 shares of Common Stock
Option exercise price: $1.26 per share
+5 more
8 metrics
Option exercise price
$1.03 per share
Stock Option (right to buy) for 116,666 underlying shares of Common Stock, expiring July 27, 2027
Underlying shares for $1.03 option
116,666 shares of Common Stock
Fully vested and exercisable stock option held directly by Dr. Wilkison
Option exercise price
$1.26 per share
Stock Option (right to buy) for 26,666 underlying shares of Common Stock, expiring January 1, 2031
Underlying shares for $1.26 option
26,666 shares of Common Stock
Vesting in three tranches on April 1, 2026, 2027 and 2028
Indirectly held common shares
1,800,000 shares of Common Stock
Held by WOWIG, LLC, of which Dr. Wilkison is the sole member
First vesting tranche
8,889 shares
Portion of $1.26 option vesting on April 1, 2026, subject to continued service
Second vesting tranche
8,889 shares
Portion of $1.26 option vesting on April 1, 2027, subject to continued service
Final vesting tranche
8,888 shares
Portion of $1.26 option vesting on April 1, 2028, subject to continued service
Key Terms
Stock Option (right to buy), exercise price, indirect, vesting
4 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
exercise price financial
"conversion_or_exercise_price: "1.0300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
indirect financial
"direct_or_indirect: "I" for Common Stock holding"
vesting financial
"The shares subject to this option vest as to 8,889 shares on April 1, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider holdings does VOGX disclose for Dr. William Wilkison on this Form 3?
Dr. Wilkison reports stock options over 116,666 shares at $1.03 and 26,666 shares at $1.26, plus 1,800,000 common shares held indirectly through WOWIG, LLC, of which he is the sole member.
What are the key terms of Dr. Wilkison’s $1.03 VOGX stock option grant?
The $1.03 stock option covers 116,666 shares of VOGX common stock, is fully vested and exercisable as of the reporting date, and has an expiration date of July 27, 2027.
How do Dr. Wilkison’s $1.26 VOGX stock options vest?
The $1.26 stock option covers 26,666 shares and vests in three tranches: 8,889 shares on April 1, 2026, 8,889 on April 1, 2027, and 8,888 on April 1, 2028, subject to Dr. Wilkison’s continued service on each vesting date.
Does this VOGX Form 3 report any insider purchases or sales?
No. The Form 3 reports holdings only, including stock options and indirectly held common shares. There are no reported buy or sell transactions in the transaction summary for this filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
